Definitive Contract 36C25221C0007
- Not listed
- This is a federal contract award to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $15,104,376.83, was awarded by the Department of Veterans Affairs (VA) and covers the provision of chemistry and immunoassay products and services. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) vehicle, and it has no set-aside...
- This federal contract award, valued at $206,474.84, was made by the Department of Veterans Affairs (VA) Veterans Health Administration to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the delivery of molecular testing supplies and is not subject to a set-aside designation. Roche Diagnostics has a history of providing critical care analyzers, reagents, test...
- This is a federal contract award to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $1,176,942.17, is a delivery order awarded by the Department of Veterans Affairs (VA) under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration (GSA) Schedule contract. The award is for CHEMISTRY ANALYZERS CPRR, with an ultimate...
- This is a federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, with a potential value of $9,644,795.85, was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration for delivery orders of chemistry-immunochemistry tests. The contract does not have a set-aside designation. Roche...
- The Department of Veterans Affairs Veterans Health Administration awarded a $426,490.53 firm-fixed-price delivery order to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. This order was placed against Roche's existing General Services Administration (GSA) Schedule contract for critical care analyzers and related laboratory equipment and supplies. The award provides chemistry analysis capabilities, including...
- This federal contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $1,691,568.24 contract is a delivery order awarded on December 1, 2018, with a completion date of May 31, 2020. It is a firm-fixed-price...
- The Department of Veterans Affairs Veterans Health Administration has awarded a $23,741.00 Firm Fixed Price Delivery Order contract to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory equipment. This contract is for the provision of coagulation testing supplies to support VA healthcare facilities. The contract has no set-aside designation and a completion date of January 31, 2024. Roche Diagnostics holds several Indefinite...
- This is a federal contract award to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $222,288.37, is a delivery order under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration (GSA) Schedule contract. The contract is for the provision of molecular infectious disease reagents to the Department of Veterans Affairs' (VA)...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed-price delivery order contract to Roche Diagnostics Corporation for in vitro diagnostic products and services. The $326,288.57 contract is funded through the Veterans Integrated Service Network 6 and provides critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services to VA hospitals. The contract was not set aside and is based on Roche's existing General Services...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 awarded a firm fixed-price delivery order contract worth $13,320.50 to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for coagulation testing and does not have a set-aside designation. Roche Diagnostics has a history of providing critical care analyzers,...
This is a federal contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The $295,346.07 Firm Fixed Price Definitive Contract provides clinical chemistry analyzers, reagents, test kits, and associated laboratory products and services to VA hospitals without a set-aside designation. Roche Diagnostics has multiple General Services Administration (GSA) Schedule contracts and Indefinite Delivery Vehicles (IDVs) with the VA, Department of Defense, and other federal agencies to supply medical equipment, consumables, and laboratory services on an as-needed basis. This specific award is part of Roche's $30 million IDC with the VA to provide chemistry analyzers and supplies to support VA hospitals in California.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | ($358k) | 8/31/23 | |
| Not listed | Not listed | $653.6k | 10/22/20 |